| abstract |
The invention relates to compounds having formula I, which block the biosynthesis of phosphorylcholine by selectively blocking the choline kinase enzyme in tumour cells or in cells affected by parasitic infection and which, as a result, can be used in the treatment of tumours and parasitic diseases or diseases caused by viruses and fungi in animals including humans. The invention also relates to a method of preparing the aforementioned compounds and to some intermediates resulting from said method. |